000			02091nam a2200481 i 4500
999			_c283197 _d283197
001			on1105990175
003			OCoLC
005			20190730185520.0
006			m o d f
007			cr gn|||||||||
008			190628s2019 dcua ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a1016-C (online)
086	0		_aY 4.OV 2:116-08
088			_aSerial no. 116-08 (United States. Congress. House. Committee on Oversight and Reform)
099			_aY 4.OV 2:116-08
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Oversight and Reform. _bSubcommittee on Economic and Consumer Policy,
245	1	0	_aExamining the public health risks of carcinogens in consumer products : _bhearing before the Subcommittee on Economic and Consumer Policy of the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, first session, March 12, 2019.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2019.
300			_a1 online resource (iii, 32 pages) : _billustration
336			_btxt
337			_2rdamedia _bn
338			_2rdacarrier _bnc
500			_a"Serial no. 116-08."
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588			_aDescription based on online resource; title from PDF title page (govinfo, viewed June 28, 2019).
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo122449
050		4	_aKF27 _b.O964 2019a
610	1	0	_aUnited States. _bFood and Drug Administration _xRules and practice.
610	2	0	_aJohnson & Johnson.
650		0	_aCosmetics _xHealth aspects _zUnited States.
650		0	_aTalc _xCarcinogenicity.
650		0	_aCosmetics industry _xGovernment policy _zUnited States.
650		0	_aConsumer protection _zUnited States.
650		0	_aCancer _zUnited States _xPrevention.
650		0	_aAsbestos _xHealth aspects _zUnited States.
650		0	_aOvaries _xCancer _xEtiology.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8